Title: Editorial: targeting aberrant hepatic inflammation for treatment of non‐alcoholic steatohepatitis—authors' reply.
Authors: Safadi, Rifaat; Braun, Marius; Francis, Adi; Milgrom, Yael; Massarwa, Muhammad; Hakimian, David; Hazou, Wadi; Issachar, Assaf; Harpaz, Zivit; Farbstein, Motti; Itzhak, Inbal; Lev‐Cohain, Naama; Bareket‐Samish, Avital; Silverman, Michael H.; Fishman, Pnina
Abstract: LINKED CONTENT: This article is linked to Safadi et al papers. To view these articles, visit https://doi.org/10.1111/apt.16664 and https://doi.org/10.1111/apt.16748
Subjects: NON-alcoholic fatty liver disease; INFLAMMATION; THERAPEUTICS; AUTHORS
Publication: Alimentary Pharmacology & Therapeutics, 2022, Vol 55, Issue 4, p485
ISSN: 0269-2813
Publication type: Academic Journal
DOI: 10.1111/apt.16762

Editorial: targeting aberrant hepatic inflammation for treatment of non‐alcoholic steatohepatitis—authors' reply.

Safadi, Rifaat; Braun, Marius; Francis, Adi; Milgrom, Yael; Massarwa, Muhammad; Hakimian, David; Hazou, Wadi; Issachar, Assaf; Harpaz, Zivit; Farbstein, Motti; Itzhak, Inbal; Lev‐Cohain, Naama; Bareket‐Samish, Avital; Silverman, Michael H.; Fishman, Pnina